Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep472 | Diabetes (complications & therapy) | ECE2015

Is diabetes an independent risk factor of perioperative complications after abdominal gynecologic interventions?

Swirska Joanna , Matyjaszek-Matuszek Beata , Czuczwar Piotr , Zwolak Agnieszka

Purpose: We sought to determine if in the group of patients who underwent gynecologic abdominal interventions diabetes was an independent risk factor of perioperative complications.Material and methods: The study group included 62 women from both the diabetic and the control group who underwent elective gynecologic laparotomies such as hysterectomy or adnexectomy. The patients from diabetic group were pair-matched with patients without diabetes based on ...

ea0035p255 | Clinical case reports Pituitary/Adrenal | ECE2014

Diabetes insipidus as the primary symptom of infundibuloma

Matyjaszek-Matuszek Beata , Pyzik Aleksandra , Zakoscielna Katarzyna , Tarach Jerzy

Introduction: Neurohormonal diabetes insipidus (DI) is a rare disorder caused by partial or total vasopressin deficiency which results in diluted urine characterized by polyuria and polydipsia. In 30–50% of the cases the cause of the disease is unknown; it is the so-called idiopathic diabetes insipidus. Other causes include: tumors of the CNS most commonly craniopharyngioma, pituitary macroadenomas, central nervous system trauma, inflammatory state of hypothalamus or pitu...

ea0035p258 | Clinical case reports Pituitary/Adrenal | ECE2014

Different courses of Carpenter syndrome

Matyjaszek-Matuszek Beata , Lenart-Lipinska Monika , Rudzki Grzegorz , Tarach Jerzy

Introduction: Autoimmune polyglandular syndrome type 2 (APS type 2) is co-occurrence of primary adrenal insufficiency (Addison disease) and autoimmune thyroid disease – most commonly Hashimoto thyroiditis (Schmidt syndrome). If it is associated with type 1 diabetes mellitus it is known as Carpenter syndrome. We present clinical pictures of two 33-year-old patients (born in 1980) diagnosed with APS type 2 manifested as Carpenter syndrome to emphasize different courses of t...

ea0035p316 | Clinical case reports Thyroid/Others | ECE2014

Severe postmenopausal virilization of unknown origin

Matyjaszek-Matuszek Beata , Lenart-Lipinska Monika , Tarach Jerzy

Introduction: The severe course of hyperandrogenism during the menopausal transition requires the exclusion of androgen-secreting tumors.Case report: A 60-year-old postmenopausal woman was referred to the Department of Endocrinology with a 3-year history of progressive development of hyperandrogenism with virilization (severe hirsutism, frontal balding, deepening of voice, increased muscle mass, and secondary polycythemia).Hormonal...

ea0014p588 | (1) | ECE2007

Hypopituitary patients have an increased prevalence of cardiovascular risk factors

Matuszek Beata , Kowalczyk Mariusz , Zapolski Tomasz , Nowakowski Andrzej

Introduction: Hypopituitary patients receiving conventional hormone replacement, but without GH replacement, have an increased mortality from cardiovascular diseases. Inadequate hormone replacement is a possible cause of this increased mortality. GH deficiency in adult patients has been associated with several cardiovascular risk factors, including hyperlipidemia, increased abdominal adiposity, and impaired insulin sensitivity.The aim of the study is an ...

ea0073aep249 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Efficacy of liraglutide in weight reduction in a patient with HAIR-AN syndrome - case report

Wasyluk Weronika , Joanna Świrska , Matyjaszek-Matuszek Beata , Zwolak Agnieszka

HAIR-AN is a rarely recognized syndrome which is characterized by hyperandrogenism (HA), insulin resistance (IR) and acanthosis nigricans (AN). In the course of the syndrome, anovulation and metabolic disorders can develop, too. It is therefore suggested by some authors that HAIR-AN is an extreme phenotype of the polycystic ovary syndrome (PCOS). Generally, considering wide spectrum of metabolic and endocrine disorders which can be associated with the syndrome, it still remain...

ea0063gp79 | Thyroid Autoimmune Disorders | ECE2019

The neutrophil-to-lymphocyte ratio as a novel marker in patients with thyroid-associated orbitopathy – a prelimininary study

Szydełko Joanna , Rodzik Beata , Tarach Jerzy , Matyjaszek-Matuszek Beata

Introduction: Graves’ orbitopathy (GO) is a rare autoimmune inflammatory disease occurring in 25–50% cases of Graves’ disease (GD). It is associated with poor clinical outcomes, impaired quality of life and socio-economic status. Genetic, environmental and immunological factors are considered to play a role in the pathogenesis of GO, but the effects of neutrophil, lymphocyte counts as well as neutrophil-to-lymphocyte ratio on the pathophysiology of GO are still ...

ea0063ep13 | Adrenal and Neuroendocrine Tumours | ECE2019

Adrenocortical carcinoma - single center experience

Zwolak Agnieszka , Tywanek Ewa , Świrska Joanna , Dudzińska Marta , Matyjaszek-Matuszek Beata , Tarach Jerzy

Adrenocortical carcinoma is an aggressive tumor of endocrine system with an annual incidence of 1–2 cases per million. The most significant prognostic factors are tumor size, disease stage at the time of putting the diagnosis and treatment method. Advanced age of the patient, and hormonal activity of the cancer are also related to poor prognosis.Materials and methods: In our study we collected data of 12 patients who were treated in Endocrinology Cl...

ea0063ep106 | Pituitary and Neuroendocrinology | ECE2019

Central resistance to thyroid hormone coexisting with autoimmune thyroid disease – case report

Szafraniec-Porada Aneta , Porada Dominik , Lenart-Lipińska Monika , Matyjaszek-Matuszek Beata

Pituitary resistance to thyroid hormone (PRTH) is a rare, genetic cause of hyperthyroidism. It is characterized by a high concentration of free thyroid hormones, coexisting with elevated or normal concentration of thyroid stimulating hormone. The most prevalent features of this syndrome are typical symptoms of hyperthyroidism and goitre. Diagnosis of this condition does not exclude other comorbidities of the thyroid gland, including these of autoimmune origin. We present the c...

ea0049ep865 | Clinical case reports - Pituitary/Adrenal | ECE2017

Pituitary apoplexy as the first manifestation of silent somatotropinoma

Obel Ewa , Lewicki Marcin , Urbanczuk Magdalena , Smolen Agata , Matyjaszek-Matuszek Beata , Tarach Jerzy

Introduction: Pituitary apoplexy is a rare endocrine disorder which can occur due to haemorrhage into pituitary gland. It is often associated with the presence of pituitary adenoma, uncommonly being the first clinical manifestation of an underlying tumour. It can cause hypopituitarism and diabetes insipidus. Pituitary adenomas are classified by their secretion properties as functional and clinically non-functioning, the latter, however, can exhibit positive immunostaining for ...